Century Therapeutics IPSC
NASDAQ IPSC
$1.65 -0.02 (-1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Non-Current Debt (2020 - 2022)

Updated

Century Therapeutics' Non-Current Debt came in at $3.74 million for Q4 2022, down 58.0% from $8.9 million a year earlier and down 39.1% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Non-Current Debt (2020 - 2022) Analysis & Trends

Going back to Q4 2020, Century Therapeutics' Non-Current Debt data covers 6 quarters.

  • Going back by year, Non-Current Debt was $8.9 million in FY2021 (-7.6%) and $9.64 million in FY2020.
  • Business Quant data shows IPSC's Non-Current Debt at $6.14 million (Q3 2022), $8.5 million (Q2 2022) and $10.02 million (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Century Therapeutics 301.51 Mn -202.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 3.74 Mn
Sep 30, 2022 6.14 Mn
Jun 30, 2022 8.50 Mn
Mar 31, 2022 10.02 Mn
Dec 31, 2021 8.90 Mn
Dec 31, 2020 9.64 Mn
API Access

Century Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=IPSC&period=max&api_key=YOUR_API_KEY